Daily SPAC Update – March 27, 2025

by | Mar 27, 2025

Oak Woods Extends to September 2025. HCM II Deal with Terrestrial Energy Announced. Aimfinity + Docter Deal Vote. Finnovate Drops Marcum.

Boardroom Alpha SPAC Resources
– Full SPAC Listing
– SPAC SEC Filings
– Boardroom Alpha IPO & SPAC Intelligence Platform (7-Day Trial)

Daily SPAC Update

SPAC VOTE RESULTS
NVAC – NORTHVIEW ACQUISITION CORP * Extend to Jun 22, 2025 * 532,958 redeemed
OAKU – OAK WOODS ACQUISITION CORP * Extend to Sep 28, 2025 * 679,929 redeemed

SPAC DEALS ANNOUNCED
Mar 26 | HOND – HCM II Acquisition Corp + Terrestrial Energy Inc.

ABOUT Terrestrial Energy Inc.

Terrestrial Energy is a developer of Generation IV nuclear plants that use its proprietary Integral Molten Salt Reactor (IMSR) technology. IMSR technology captures the full transformative operating benefits of molten salt reactor technology in a plant design that represents true innovation in cost reduction, versatility and functionality of nuclear energy supply. IMSR plants will supply zero-carbon, reliable, dispatchable, low-cost, high-temperature industrial heat and electricity for a dual-use energy role relevant to many industrial applications, such as chemical synthesis and desalination. In so doing, they extend the application of nuclear energy far beyond electric power markets. IMSR plants have the potential to make substantial contributions to industrial competitiveness, energy security, and economic growth. Their deployment will support rapid global decarbonization of the primary energy system across a broad spectrum. Terrestrial Energy uses an innovative design, together with proven and demonstrated molten salt reactor technology, which offers a unique set of operating characteristics to deliver high and compelling commercial potential. Terrestrial Energy is engaged with regulators, suppliers and industrial partners to build, license and commission the first IMSR plants in the early 2030s.

MERGER VOTES
AIMAU – Aimfinity Investment Corp I + Docter Inc
Since 2016, Docter, along with its subsidiary, Horn Enterprise Co., Ltd., has been developing a non-invasive blood sugar trend monitoring technology, alleviating the necessity for blood sampling. The company operates Docter brand watches and employs Docter Cloud platform technologies to facilitate health monitoring, vascular elasticity tracking, and myocardial infarction prediction. Additionally, Docter has made investments in the development of biological radar wave technology to cater to those requiring long-term care or individuals experiencing sub-optimal health.

OTHER SPAC NEWS
DPCS – DP CAP ACQUISITION CORP I * Dismissed Accountant
FNVTF – FINNOVATE ACQUISITION CORP * Dismissed Accountant
HUDA – HUDSON ACQUISITION I CORP * Delisting
HUDA – HUDSON ACQUISITION I CORP * Merger Agreement Amendment

YESTERDAY’S TOP SPAC GAINERS
11.37% ~ $ 16.26 | GATE – MARBLEGATE ACQUISITION CORP (Announced)
6.51% ~ $ 10.80 | HOND – HCM II ACQUISITION CORP (Announced)
1.22% ~ $ 10.78 | CCIX – CHURCHILL CAPITAL CORP IX (Pre-Deal)
1.18% ~ $ 10.25 | BSII – BLACK SPADE ACQUISITION II CO (Announced)
.85% ~ $ 11.85 | SKGR – SK GROWTH OPPORTUNITIES CORP (Announced)

YESTERDAY’S TOP SPAC LOSERS
-8.78% ~ $ 6.75 | BOWN – BOWEN ACQUISITION CORP (Announced)
-8.40% ~ $ 13.09 | AIMAU – AIMFINITY INVESTMENT CORP I (Announced)
-3.52% ~ $ 12.06 | WINV – WINVEST ACQUISITION CORP (Announced)
-1.19% ~ $ 11.61 | BNIX – BANNIX ACQUISITION CORP (Pre-Deal)
-1.06% ~ $ 11.20 | BUJA – BUKIT JALIL GLOBAL ACQUISITION 1 LTD (Announced)

LATEST SPAC IPO PERFORMANCE
Mar 21 | $ 10.03 | GSHR – Gesher Acquisition Corp. II
Mar 17 | $ 10.10 | QSEA – Quartzsea Acquisition Corp
Feb 27 | $ 10.11 | LOKV – Live Oak Acquisition Corp. V
Feb 27 | $ 10.03 | NHIC – NewHold Investment Corp. III
Feb 27 | $ 10.07 | FERA – Fifth Era Acquisition Corp I
Feb 26 | $ 10.06 | RAC – Rithm Acquisition Corp.

 

Recent Analysis

Weekly Boardroom & Executive Moves: May 1, 2026

This week, significant leadership changes occurred across several companies facing financial difficulties. Abbott Laboratories (ABT) and Agilon Health Inc (AGL) appointed new board members and executives amidst high activist risks and declining TSRs. Accuray Inc (ARAY) and ALT5 Sigma Corp (ALTS) also saw key executive departures and appointments as they navigate substantial TSR declines. These shifts highlight the ongoing challenges and strategic redirections needed to stabilize operations and improve shareholder value.

Daily SPAC Update – May 1, 2026

Two SPAC IPOs launched today, raising a total of $500 million. CH4 Natural Solutions Acquisition Corp (MTNE) secured $300 million, while Quantum Leap Acquisition Corp (QLEP) raised $200 million. Today, 2 SPAC IPOs raised $500M, led by CH4 Natural Solutions (MTNE) at $300M. This follows a surge of activity at the end of April.

Daily SPAC Update – April 30, 2026

Today, six SPACs debuted, raising a total of $965 million. General Catalyst Global Resilience Merger Corp (GCGR) led the pack with $350 million, followed by RRE Ventures Acquisition Corp. (RREV) at $250 million. Month-to-date, SPAC IPOs total 16, bringing in $2.65 billion, compared to 11 IPOs last month that raised $1.72 billion.

Daily SPAC Update – April 29, 2026

Collective Acquisition Corp. II (CAII) launched its $220 million IPO today, targeting high-potential sectors like technology and healthcare. In executive moves, Roger Bendelac was appointed CEO of both Drugs Made in America Acquisition Corp (DMAA) and Drugs Made in America Acquisition II Corp (DMII), with Saleem Elmasri as CFO. Meanwhile, General Purpose Acquisition Corp (GPAC) saw a significant decline of 22.9%, closing at $9.96, while Aimei Health Technology Co Ltd (AFJK) gained 2.7% to $46.12.

Daily SPAC Update – April 28, 2026

SPAC IPOs Look Stalled Again as Irenic’s $220M IPO Only Makes it Seven. Miluna Acquisition + CADV.AI Deal. Prophyte Extension Vote to Add 12 More Months.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.